263 related articles for article (PubMed ID: 10894808)
1. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection.
Carr AC; McCall MR; Frei B
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1716-23. PubMed ID: 10894808
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis.
Heinecke JW
Curr Opin Lipidol; 1997 Oct; 8(5):268-74. PubMed ID: 9335950
[TBL] [Abstract][Full Text] [Related]
3. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein.
Byun J; Mueller DM; Fabjan JS; Heinecke JW
FEBS Lett; 1999 Jul; 455(3):243-6. PubMed ID: 10437781
[TBL] [Abstract][Full Text] [Related]
4. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress.
Heinecke JW
Free Radic Biol Med; 2002 Jun; 32(11):1090-101. PubMed ID: 12031894
[TBL] [Abstract][Full Text] [Related]
5. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.
Heinecke JW
Biofactors; 1997; 6(2):145-55. PubMed ID: 9259996
[TBL] [Abstract][Full Text] [Related]
6. p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.
Exner M; Alt E; Hermann M; Hofbauer R; Kapiotis S; Quehenberger P; Speiser W; Minar E; Gmeiner B
FEBS Lett; 2001 Feb; 490(1-2):28-31. PubMed ID: 11172805
[TBL] [Abstract][Full Text] [Related]
7. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.
Podrez EA; Schmitt D; Hoff HF; Hazen SL
J Clin Invest; 1999 Jun; 103(11):1547-60. PubMed ID: 10359564
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
10. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
11. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima.
Leeuwenburgh C; Hardy MM; Hazen SL; Wagner P; Oh-ishi S; Steinbrecher UP; Heinecke JW
J Biol Chem; 1997 Jan; 272(3):1433-6. PubMed ID: 8999808
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL).
Zuckerman SH; Bryan N
Atherosclerosis; 1996 Sep; 126(1):65-75. PubMed ID: 8879435
[TBL] [Abstract][Full Text] [Related]
13. The role of oxidized lipoproteins in atherogenesis.
Berliner JA; Heinecke JW
Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
[TBL] [Abstract][Full Text] [Related]
14. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms.
Kalyanaraman B
Redox Biol; 2013 Feb; 1(1):244-57. PubMed ID: 24024158
[TBL] [Abstract][Full Text] [Related]
15. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein.
Jessup W; Mohr D; Gieseg SP; Dean RT; Stocker R
Biochim Biophys Acta; 1992 Oct; 1180(1):73-82. PubMed ID: 1327163
[TBL] [Abstract][Full Text] [Related]
16. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
17. Effect of acetaminophen on the myeloperoxidase-hydrogen peroxide-nitrite mediated oxidation of LDL.
Chou TM; Greenspan P
Biochim Biophys Acta; 2002 Mar; 1581(1-2):57-63. PubMed ID: 11960752
[TBL] [Abstract][Full Text] [Related]
18. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
Aviram M
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
[TBL] [Abstract][Full Text] [Related]
19. Basic research in antioxidant inhibition of steps in atherogenesis.
Gokce N; Frei B
J Cardiovasc Risk; 1996 Aug; 3(4):352-7. PubMed ID: 8946264
[TBL] [Abstract][Full Text] [Related]
20. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Aviram M
Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
